Hudson Bay Capital Management’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-99,999
| Closed | -$1.01M | – | 1115 |
|
|
2022
Q4 | $1.01M | Hold |
99,999
| – | – | 0.01% | 650 |
|
|
2022
Q3 | $992K | Hold |
99,999
| – | – | 0.01% | 811 |
|
|
2022
Q2 | $978K | Hold |
99,999
| – | – | 0.01% | 892 |
|
|
2022
Q1 | $974K | Hold |
99,999
| – | – | 0.01% | 810 |
|
|
2021
Q4 | $969K | Hold |
99,999
| – | – | 0.01% | 787 |
|
|
2021
Q3 | $967K | Hold |
99,999
| – | – | 0.01% | 730 |
|
|
2021
Q2 | $966K | Buy |
+99,999
| New | +$966K | 0.01% | 722 |
|